Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |